Introduction to Controlling Polymorphic Impurities In Pharmaceutical Processes
Welcome to our comprehensive guide on Controlling Polymorphic Impurities In Pharmaceutical Processes. In this webinar, guest speaker Jude Eames from Eurofins CDMO Alphora will share a case study on
Controlling Polymorphic Impurities In Pharmaceutical Processes Comprehensive Overview
POLYMORPHISM Dr. Steven Baertschi delivered this talk in South San Francisco, CA on October 31, 2018. Development and implementation of ... Dr. Rajesh Shukla, Vice President Research and Development at PCI Synthesis Talks about
This is an edited version of the webinar aired live on October 26, 2021. Speaker is Christian Zeine, Scientific Affairs Manager.
Summary & Highlights for Controlling Polymorphic Impurities In Pharmaceutical Processes
- Polymorphism
- nitrosamines #
- Polymorphism
- Genotoxic
- Nitrosamine
In summary, understanding Controlling Polymorphic Impurities In Pharmaceutical Processes gives us a better perspective.
